Influence of ESGC Indicators on Financial Performance of Listed Pharmaceutical Companies
Open Access
- 25 April 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (9) , 4556
Abstract
The pharmaceutical industry, concerned about the impact of its activity, has integrated responsible principles and practices with a view to improving its sustainable and financial performance. This study analyzes the relationship between environmental, social, governance, and controversy indicators and financial performance, measured through return on equity (ROA), return on assets (ROE), and Tobin’s Q, which are applied to the listed companies in the Nasdaq US Smart Pharmaceuticals Index. This index is composed of 30 international companies with a presence at the global level. All the data have been extracted from the Thomson Reuters database. The analysis was performed using structural equation modeling implemented with partial least squares. The results confirm the positive relationship between the construct composed of environmental, social, and governance (ESG) indicators and the aforementioned financial ratios. Additionally, a positive relationship of the controversy indicator with Tobin’s Q is supported. This suggests that the pharmaceutical multinationals focus their investments in sustainability on ESG and pay attention to controversies to boost the visibility of the company and thus increase its value. These conclusions confirm that investing in ESG is a profitable strategy. It is also relevant for managers as it increases the profits and the market value of multinational pharmaceutical companies.Keywords
This publication has 99 references indexed in Scilit:
- Human Health Risk Assessment of Pharmaceuticals in Water: Issues and Challenges AheadInternational Journal of Environmental Research and Public Health, 2010
- Why Go Green? The Business Case for Environmental Commitment in the Canadian Hotel IndustryAnatolia, 2008
- Corporate social responsibility practices in the pharmaceutical industryBusiness Strategy Series, 2008
- The Worth of Values – A Literature Review on the Relation Between Corporate Social and Financial PerformanceJournal of Business Ethics, 2008
- Corporate Social Responsibility (CSR): Models and Theories in Stakeholder DialogueJournal of Business Ethics, 2008
- DialogueAcademy of Management Review, 1998
- A Natural-Resource-Based View of the FirmAcademy of Management Review, 1995
- The Stakeholder Theory of the Corporation: Concepts, Evidence, and ImplicationsAcademy of Management Review, 1995
- The Predictive Sample Reuse Method with ApplicationsJournal of the American Statistical Association, 1975
- Coefficient Alpha and the Internal Structure of TestsPsychometrika, 1951